Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial

MLA

Raphael Schiffmann, et al. Venglustat Combined with Imiglucerase for Neurological Disease in Adults with Gaucher Disease Type 3: The LEAP Trial. Feb. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ed219c4759532a6c770f7c376cc91518&authtype=sso&custid=ns315887.

APA

Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu, Sebastiaan J M Gaemers, Julia B Hennermann, Hiroyuki Ida, Eugen Mengel, Pascal Minini, Pramod Mistry, Petra B Musholt, David Scott, Jyoti Sharma, & M Judith Peterschmitt. (2023). Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.

Chicago

Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu, Sebastiaan J M Gaemers, Julia B Hennermann, Hiroyuki Ida, Eugen Mengel, et al. 2023. “Venglustat Combined with Imiglucerase for Neurological Disease in Adults with Gaucher Disease Type 3: The LEAP Trial,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ed219c4759532a6c770f7c376cc91518&authtype=sso&custid=ns315887.